FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Clears GE Pulse Imaging System

FDA clears a GE HealthCare 510(k) for its Allia IGS Pulse imaging system.

latest-news-card-1
Medical Devices

Praxis 510(k) for Biopsy Device Cleared

FDA clears a Praxis Medical 510(k) for its EndoCore EBUS-TBNA fine needle biopsy device.

latest-news-card-1
FDA General

Former FDA Lawyer Joins Faegre Drinker

After 15 years at FDA, former senior regulatory counsel Joy Sharp joins the law firm Faegre Drinker as counsel in Washington, DC.

latest-news-card-1
Human Drugs

Keytruda OKd Before/After Lung Cancer Surgery

FDA approves Mercks Keytruda (pembrolizumab) for use with platinum-containing chemotherapy as neoadjuvant treatment and continuing as a single-agent p...

latest-news-card-1
Federal Register

Testing Pharma Alcohols for Methanol Guide

Federal Register notice: FDA makes available a final guidance entitled Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol.

latest-news-card-1
Federal Register

Guide on Diabetic Foot Infection Drugs

Federal Register notice: FDA makes available a draft guidance entitled Diabetic Foot Infections: Developing Drugs for Treatment.

latest-news-card-1
FDA General

Is Chevron Deference Dead?: Ex-FDAer Pitts

Former FDAer Peter Pitts asks if FDA is going too far in seeking deference in a court case involving Regenative Labs Whartons Jelly Tissue Allografts....

latest-news-card-1
Medical Devices

Guilty Plea in SphenoCath Case

The Justice Department says former Dolor Technologies CEO Mark Wright has pleaded guilty to misdemeanor charges of introducing adulterated and misbran...

latest-news-card-1
Human Drugs

FDA Wants Comments on Innovative Clinical Trials

CDER asks for comments on barriers and facilitators to incorporating innovative clinical trials in drug development programs.

latest-news-card-1
Human Drugs

Verrica Asks FDA to End Ycanth Compounding

Verrica Pharmaceuticals asks FDA to take steps to stop the compounding of its Ycanth molluscum contagiosum treatment.